Los puntos clave no están disponibles para este artículo en este momento.
Impella 2.5 (pLVAD) support protected against AKI during high-risk PCI. This renal protective effect persisted despite the presence of underlying CKD and decreasing ejection fraction.
Flaherty et al. (Wed,) studied this question.